Self-Administered Drugs Market
Global Self-Administered Drugs Market Size, Share and Trends Analysis Report, by Product Type (Injectable Drugs, Inhaled Drugs, and Transdermal Drugs), by Application (Cardiovascular, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, and Others), Forecast Period (2022-2028) Update Available - Forecast 2024-2030
The global self-administered drugs market is anticipated to grow at a CAGR of 8.3% during the forecast period. High healthcare service costs which encourage patients to adopt self-administered drugs also contribute to the growth of this market. Self-administered drugs are majorly taken by diabetic patients for injecting insulin without the prior need of any healthcare professional assistance. The foremost factors leading to the self-administered drug market expansion include the increasing prevalence of diabetes and the rising burden of chronic diseases globally. As per the British Diabetic Association, in the UK, 3.8 million people are living with a diagnosis of diabetes, and 90% of those with type 2, and around 5.5 million people are expected to have diabetes in the UK by 2030.
Apart from these, the rising FDA approvals of new drugs developed by prominent players targeting the self-administered drugs market create new growth opportunities for the market. In May 20201, the USFDA approved Eli Lilly and Company's Mounjaro (tirzepatide) injection. It is a new once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. However, lack of awareness about self-administered drugs in emerging countries and low or no reimbursement for some self-administered drugs are the restraints that may hamper the revenue growth of the self-administered drugs market during the forecast period.
Segmental Outlook
The global self-administered drugs market is segmented based on product type, and application. Based on product type, the market is sub-segmented into injectable drugs, inhaled drugs, and transdermal drugs. Among these, injectable self-administered drugs have gained immense popularity, especially among patients suffering from a diabetic condition that requires regular insulin intake and patients suffering from chronic diseases such as multiple sclerosis, rheumatoid arthritis, diabetes, and others. Apart from these, the high cost of medication expenditure involve in a healthcare setting is also a prominent reason, people are shifting towards the injectable segment. Rising trends of drug delivery at home along with comfort are also factors that will positively impact injectable segment growth. Based on application, the market is further categorized into cardiovascular, diabetes, osteoporosis, pain management, hormone replacement, and others.
Regional Outlook
Geographically, the global self-administered drugs market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). The Asia-Pacific region is projected to show the fastest growth in the self-administered drugs market during the forecast period. The growing geriatric population, high prevalence of chronic diseases, and availability of self-administered drugs along with self-administered drug injectable devices are motivating people to choose outpatient services that are enhancing the overall market growth.
Global Self-Administered Drugs Market Growth by Region, 2022-2028
North America Dominates in Self-Administered Drugs Market
Geographically, the North American region dominated the market by holding the highest market share in 2021. The region is further projected to rule the self-administered drugs market during the forecast period. The regional growth is driven by the increasing incidence of cancer, bone disorders, diabetes, and robust demand for self-administered drugs among patients dealing with such diseases. Moreover, the government in the region’s major economies is also supported by providing insurance for some self-administered drug adoption. Surging USFDA approvals for drugs opens the path for new growth opportunities for market players. For instance, in June 2020 Eli Lilly and Company's got other approvals from USFDA for its “Lyumjev”, new rapid-acting insulin indicated to improve glycemic control in adults with type 1 and type 2 diabetes. Lyumjev is a novel formulation of insulin lispro. The product is developed by the company to speed the absorption of insulin into the bloodstream and reduce A1C levels. It also controls high blood sugar levels after meals in adults with diabetes. Similarly, in March 2021, Abbott got approval from the USFDA for over-the-counter, non-prescription, asymptomatic use of its BinaxNOW COVID-19 Ag Self-Test for detection of COVID-19 infection. This new indication allows individuals with or without symptoms to have access to this test without a prescription.
Market Players Outlook
The major market players in the global self-administered drugs market include Bristol-Myers Squibb, Abbott Laboratories, Gilead Sciences, Eli Lilly and Company, Antares Pharma, and Novartis AG., among others. The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new drug development, to stay competitive in the market.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global self-administered drugs market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Self-Administered Drugs Industry
• Recovery Scenario of Global Self-Administered Drugs Industry
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
4. Market Segmentation
4.1. Global Self-Administered Drugs Market by Product Type
4.1.1. Injectable Drugs
4.1.2. Inhaled Drugs
4.1.3. Transdermal Drugs
4.2. Global Self-Administered Drugs Market by Application
4.2.1. Cardiovascular
4.2.2. Diabetes
4.2.3. Osteoporosis
4.2.4. Pain Management
4.2.5. Hormone Replacement
4.2.6. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
5.4.1. Latin America
5.4.2. Middle East & Africa
6. Company Profiles
6.1. Abbott Laboratories
6.2. Amgen, Inc.
6.3. Antares Pharma, Inc.
6.4. Baxter International, Inc.
6.5. Bristol-Myers Squibb, Co.
6.6. Eli Lilly & Co.
6.7. Gilead Sciences, Inc.
6.8. Johnson & Johnson Services, Inc.
6.9. Merck & Co. Inc.
6.10. Moderna, Inc.
6.11. Mylan N.V.
6.12. Novartis International AG
6.13. Novo Nordisk AS
6.14. Pfizer, Inc.
6.15. Purdue Pharma LP
6.16. Sanofi S.A.
6.17. Teva Pharmaceuticals Industries, Ltd.
1. GLOBAL SELF-ADMINISTERED DRUGS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
2. GLOBAL INJECTABLE SELF-ADMINISTERED DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL INHALED SELF-ADMINISTERED DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL TRANSDERMAL SELF-ADMINISTERED DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL SELF-ADMINISTERED DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
6. GLOBAL SELF-ADMINISTERED DRUGS IN CARDIOVASCULAR MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL SELF-ADMINISTERED DRUGS IN DIABETES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL SELF-ADMINISTERED DRUGS IN OSTEOPOROSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL SELF-ADMINISTERED DRUGS IN PAIN MANAGEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL SELF-ADMINISTERED DRUGS IN HORMONE REPLACEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL SELF-ADMINISTERED DRUGS IN OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL SELF-ADMINISTERED DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. NORTH AMERICAN SELF-ADMINISTERED DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
14. NORTH AMERICAN SELF-ADMINISTERED DRUGS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
15. NORTH AMERICAN SELF-ADMINISTERED DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
16. EUROPEAN SELF-ADMINISTERED DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
17. EUROPEAN SELF-ADMINISTERED DRUGS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
18. EUROPEAN SELF-ADMINISTERED DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
19. ASIA-PACIFIC SELF-ADMINISTERED DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
20. ASIA-PACIFIC SELF-ADMINISTERED DRUGS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
21. ASIA-PACIFIC SELF-ADMINISTERED DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
22. REST OF THE WORLD SELF-ADMINISTERED DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
23. REST OF THE WORLD SELF-ADMINISTERED DRUGS MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2021-2028 ($ MILLION)
24. REST OF THE WORLD SELF-ADMINISTERED DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. GLOBAL SELF-ADMINISTERED DRUGS MARKET SHARE BY PRODUCT TYPE, 2021 VS 2028 (%)
2. GLOBAL SELF-ADMINISTERED DRUGS MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
3. GLOBAL SELF-ADMINISTERED DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
4. GLOBAL INJECTABLE SELF-ADMINISTERED DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
5. GLOBAL INHALED SELF-ADMINISTERED DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
6. GLOBAL TRANSDERMAL SELF-ADMINISTERED DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
7. GLOBAL SELF-ADMINISTERED DRUGS IN CARDIOVASCULAR MARKET SHARE BY REGION, 2021 VS 2028 (%)
8. GLOBAL SELF-ADMINISTERED DRUGS IN DIABETES MARKET SHARE BY REGION, 2021 VS 2028 (%)
9. GLOBAL SELF-ADMINISTERED DRUGS IN OSTEOPOROSIS MARKET SHARE BY REGION, 2021 VS 2028 (%)
10. GLOBAL SELF-ADMINISTERED DRUGS IN PAIN MANAGEMENT MARKET SHARE BY REGION, 2021 VS 2028 (%)
11. GLOBAL SELF-ADMINISTERED DRUGS IN HORMONE REPLACEMENT MARKET SHARE BY REGION, 2021 VS 2028 (%)
12. GLOBAL SELF-ADMINISTERED DRUGS IN OTHER APPLICATIONS MARKET SHARE BY REGION, 2021 VS 2028 (%)
13. US SELF-ADMINISTERED DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
14. CANADA SELF-ADMINISTERED DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
15. UK SELF-ADMINISTERED DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
16. FRANCE SELF-ADMINISTERED DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
17. GERMANY SELF-ADMINISTERED DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
18. ITALY SELF-ADMINISTERED DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
19. SPAIN SELF-ADMINISTERED DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
20. REST OF EUROPE SELF-ADMINISTERED DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
21. INDIA SELF-ADMINISTERED DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
22. CHINA SELF-ADMINISTERED DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
23. JAPAN SELF-ADMINISTERED DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
24. SOUTH KOREA SELF-ADMINISTERED DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
25. REST OF ASIA-PACIFIC SELF-ADMINISTERED DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
26. REST OF THE WORLD SELF-ADMINISTERED DRUGS MARKET SIZE, 2021-2028 ($ MILLION
